Literature DB >> 24890072

Markers of inflammation in schizophrenia: association vs. causation.

Peter Manu1, Christoph U Correll, Martien Wampers, Alex J Mitchell, Michel Probst, Davy Vancampfort, Marc De Hert.   

Abstract

Entities:  

Year:  2014        PMID： 24890072      PMCID： PMC4102292          DOI： 10.1002/wps.20117

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  42 in total

Review 1.  Inflammation and schizophrenia.

Authors:  Brian Kirkpatrick; Brian J Miller
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

Review 2.  Impact of inflammation on neurotransmitter changes in major depression: an insight into the action of antidepressants.

Authors:  Brian E Leonard
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-11-02       Impact factor: 5.067

Review 3.  The cytokine model of schizophrenia: emerging therapeutic strategies.

Authors:  Ragy R Girgis; Samhita S Kumar; Alan S Brown
Journal:  Biol Psychiatry       Date:  2013-12-11       Impact factor: 13.382

4.  The macrophage-T-lymphocyte theory of schizophrenia: additional evidence.

Authors:  R S Smith; M Maes
Journal:  Med Hypotheses       Date:  1995-08       Impact factor: 1.538

Review 5.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

6.  The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms.

Authors:  M J Schwarz; N Müller; M Riedel; M Ackenheil
Journal:  Med Hypotheses       Date:  2001-04       Impact factor: 1.538

7.  Production of interferon-gamma in families with multiple occurrence of schizophrenia.

Authors:  V Arolt; C Weitzsch; I Wilke; A Nolte; M Pinnow; M Rothermundt; H Kirchner
Journal:  Psychiatry Res       Date:  1997-02-07       Impact factor: 3.222

Review 8.  Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Authors:  M Bryant Howren; Donald M Lamkin; Jerry Suls
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

Review 9.  A review of anti-inflammatory agents for symptoms of schizophrenia.

Authors:  William R Keller; Lionel M Kum; Heidi J Wehring; Maju Mathew Koola; Robert W Buchanan; Deanna L Kelly
Journal:  J Psychopharmacol       Date:  2012-11-13       Impact factor: 4.153

10.  Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations?

Authors:  Stefan Busse; Mandy Busse; Kolja Schiltz; Hendrik Bielau; Tomasz Gos; Ralf Brisch; Christian Mawrin; Andrea Schmitt; Wolfgang Jordan; Ulf J Müller; Hans-Gert Bernstein; Bernhard Bogerts; Johann Steiner
Journal:  Brain Behav Immun       Date:  2012-08-14       Impact factor: 7.217
View more
  17 in total

1.  BACE1-Deficient Mice Exhibit Alterations in Immune System Pathways.

Authors:  L Stertz; V Contreras-Shannon; N Monroy-Jaramillo; J Sun; C Walss-Bass
Journal:  Mol Neurobiol       Date:  2016-12-21       Impact factor: 5.590

2.  Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls.

Authors:  Christoph U Correll; Marco Solmi; Nicola Veronese; Beatrice Bortolato; Stella Rosson; Paolo Santonastaso; Nita Thapa-Chhetri; Michele Fornaro; Davide Gallicchio; Enrico Collantoni; Giorgio Pigato; Angela Favaro; Francesco Monaco; Cristiano Kohler; Davy Vancampfort; Philip B Ward; Fiona Gaughran; André F Carvalho; Brendon Stubbs
Journal:  World Psychiatry       Date:  2017-06       Impact factor: 49.548

3.  Introduction.

Authors:  Paulo Lizano
Journal:  Harv Rev Psychiatry       Date:  2022 Jan-Feb 01       Impact factor: 3.732

Review 4.  Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Neuropsychopharmacology       Date:  2016-09-22       Impact factor: 7.853

5.  Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis.

Authors:  Davy Vancampfort; Brendon Stubbs; Alex J Mitchell; Marc De Hert; Martien Wampers; Philip B Ward; Simon Rosenbaum; Christoph U Correll
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

6.  Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis.

Authors:  Davy Vancampfort; Christoph U Correll; Britta Galling; Michel Probst; Marc De Hert; Philip B Ward; Simon Rosenbaum; Fiona Gaughran; John Lally; Brendon Stubbs
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

Review 7.  Cardiorespiratory Fitness in Severe Mental Illness: A Systematic Review and Meta-analysis.

Authors:  Davy Vancampfort; Simon Rosenbaum; Felipe Schuch; Philip B Ward; Justin Richards; James Mugisha; Michel Probst; Brendon Stubbs
Journal:  Sports Med       Date:  2017-02       Impact factor: 11.136

8.  omicsNPC: Applying the Non-Parametric Combination Methodology to the Integrative Analysis of Heterogeneous Omics Data.

Authors:  Nestoras Karathanasis; Ioannis Tsamardinos; Vincenzo Lagani
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

9.  Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis.

Authors:  David Fraguas; Covadonga M Díaz-Caneja; Miriam Ayora; Fabián Hernández-Álvarez; Alberto Rodríguez-Quiroga; Sandra Recio; Juan C Leza; Celso Arango
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 7.348

10.  Physical Functional Capacity and C-Reactive Protein in Schizophrenia.

Authors:  Michele Fonseca Vieira Szortyka; Viviane Batista Cristiano; Keila Maria Ceresér; Lenise Petter Francesconi; Maria Inês Lobato; Clarissa Gama; Paulo Belmonte-de-Abreu
Journal:  Front Psychiatry       Date:  2016-08-05       Impact factor: 4.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.